# Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study

> **NCT01533493** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 33 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)
- Executive Function Deficits (EFD)

## Interventions

- **DRUG:** Placebo
- **DRUG:** Memantine Hydrochloride
- **DRUG:** OROS-Methylphenidate

## Key facts

- **NCT ID:** NCT01533493
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2014-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533493, "Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01533493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*